Physician profile
Anthony Magnano
NPI 1164494563
$23,242.14
in general payments reported to CMS, 2019-2025
28 companies · $639 in 2025
The $639 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12K · 2020: $2,156 · 2021: $2,937 · 2022: $2,896 · 2023: $261 · 2024: $2,073 · 2025: $639.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,213 · Travel and Lodging: $760.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,212.62 |
| Travel and Lodging | $759.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $9,491.28 | 2019-2023 | Xarelto |
| Medtronic, INC. | $3,799.44 | 2021-2025 | Arctic Front Advance, Affera Mapping System |
| Medtronic Vascular, INC. | $3,139.12 | 2019-2020 | |
| Boston Scientific Corporation | $2,785.48 | 2019-2025 | Watchman Flx, Rhythmia Mapping System, Lux-Dx Insertable Cardiac Monitor |
| Biosense Webster, INC. | $1,308.02 | 2019-2025 | Carto 3, Qdot Micro Catheter, Nuvision Ice Catheter |
| Altathera Pharmaceuticals LLC | $500.00 | 2021 | |
| Abbott Laboratories | $472.35 | 2019-2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $238.74 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $219.72 | 2019-2022 | |
| Haemonetics Corporation | $149.84 | 2021 | |
| Cardiva Medical, INC. | $142.67 | 2025 | Cardiva Vascade Mvp Xl Vvcs 10-12f |
| Atricure, INC. | $141.39 | 2019 | |
| Abiomed | $131.58 | 2019 | |
| Edwards Lifesciences Corporation | $123.43 | 2021 | |
| Irhythm Technologies, INC. | $108.59 | 2019 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $83.72 | 2019 | |
| Elutia, INC. | $75.37 | 2019-2023 | |
| Sanofi-Aventis U.S. LLC | $64.90 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $59.27 | 2019 | |
| Shockwave Medical, INC | $55.50 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Astellas Pharma US INC | $40.98 | 2019 | |
| Acutus Medical, INC. | $34.26 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $17.39 | 2019 | |
| Braemar Manufacturing, LLC | $17.03 | 2019 | |
| Convatec INC. | $16.18 | 2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.39 | 2019 | |
| Pfizer INC. | $11.50 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Magnano listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.